|
ZNF700 expression based on
|
KIRP : Kidney renal papillary cell carcinoma
| Comparison | Statistical significance |
| Normal-vs-Primary | 8.17830000000574E-05 |
|
KIRP : Kidney renal papillary cell carcinoma Note
Cancer stage information is not available for 89 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
1.679160E-03 |
| Normal-vs-Stage2 |
6.346100E-02 |
| Normal-vs-Stage3 |
9.046400E-01 |
| Normal-vs-Stage4 |
9.252800E-01 |
| Stage1-vs-Stage2 |
3.952400E-01 |
| Stage1-vs-Stage3 |
9.483200E-03 |
| Stage1-vs-Stage4 |
3.251700E-02 |
| Stage2-vs-Stage3 |
7.341600E-02 |
| Stage2-vs-Stage4 |
7.914100E-02 |
| Stage3-vs-Stage4 |
9.956400E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient race information is not available for 15 samples and two samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
2.395200E-04 |
| Normal-vs-AfricanAmerican |
7.698400E-03 |
| Normal-vs-Asian |
4.038000E-01 |
| Caucasian-vs-AfricanAmerican |
7.658200E-01 |
| Caucasian-vs-Asian |
7.425000E-01 |
| AfricanAmerican-vs-Asian |
8.604400E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
6.24719999999801E-05 |
| Normal-vs-Female |
1.394380E-02 |
| Male-vs-Female |
4.745000E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient BMI information is not available for 72 samples.
| Descriptions |
| Normal weight |
BMI greater than equal to 18.5 and BMI less than 25 |
Extereme weight |
BMI greater than equal to 25 and BMI less than 30 |
| Obese |
BMI greater than equal to 30 and BMI less than 40 |
Extreme Obese |
BMI greater than 40 |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Normal_Weight |
3.940300E-02 |
| Normal-vs-Extreme_Weight |
6.860700E-03 |
| Normal-vs-Obese |
4.401600E-03 |
| Normal-vs-Extreme_Obese |
4.059600E-01 |
| Normal_Weight-vs-Extreme_Weight |
9.870000E-01 |
| Normal_Weight-vs-Obese |
6.852000E-01 |
| Normal_Weight-vs-Extreme_Obese |
6.663800E-01 |
| Extreme_Weight-vs-Obese |
6.036800E-01 |
| Extreme_Weight-vs-Extreme_Obese |
6.329000E-01 |
| Obese-vs-Extreme_Obese |
4.922800E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient age information is not available for 3 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
4.490100E-02 |
| Normal-vs-Age(41-60Yrs) |
7.77310000000808E-05 |
| Normal-vs-Age(61-80Yrs) |
1.279160E-03 |
| Normal-vs-Age(81-100Yrs) |
6.605600E-01 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
6.372400E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
4.483200E-01 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
5.705700E-02 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
4.642000E-01 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
3.267800E-02 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
1.042380E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma NOTE
Histology information is not available for 17 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-VS-Type1 PRCC |
5.84370000167311E-08 |
| Normal-VS-Type2 PRCC |
3.703400E-01 |
| Normal-VS-KIRP CIMP |
7.701200E-01 |
| Normal-VS-Unclassified PRCC |
4.344100E-02 |
| Type1 PRCC-VS-Type2 PRCC |
7.53619389115556E-12 |
| Type1 PRCC-VS-KIRP CIMP |
2.497600E-03 |
| Type1 PRCC-VS-Unclassified PRCC |
8.483900E-02 |
| Type2 PRCC-VS-KIRP CIMP |
4.168600E-01 |
| Type2 PRCC-VS-Unclassified PRCC |
6.699500E-03 |
| KIRP CIMP-VS-Unclassified PRCC |
2.978800E-01 |
|
Histologic PRCC subtypes: Ricketts CJ et al, The Cancer Genome Atlas Comprehensive Molecular Characterization of Renal Cell Carcinoma. Cell Rep. 2018 Apr 3;23(1):313-326.e5. doi: 10.1016/j.celrep.2018.03.075
|
KIRP : Kidney renal papillary cell carcinoma Note
Nodal metastais status is not available for 1 sample and cancer in nearby lymph nodes cannot be measured (NX) in 211 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
8.624400E-02 |
| Normal-vs-N1 |
2.093000E-01 |
| Normal-vs-N2 |
2.084200E-01 |
| N0-vs-N1 |
7.228000E-01 |
| N0-vs-N2 |
2.196800E-01 |
| N1-vs-N2 |
1.548980E-01 |
|
|
